Structure of phosphoserine aminotransferase from Mycobacterium tuberculosis

Fasseli J Coulibaly, Edouard Lassalle, Heather M Baker, Edward N Baker

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Mycobacterium tuberculosis (Mtb), the causative agent of TB, remains a serious world health problem owing to limitations of the available drugs and the emergence of resistant strains. In this context, key biosynthetic enzymes from Mtb are attractive targets for the development of new therapeutic drugs. Here, the 1.5 A resolution crystal structure of Mtb phosphoserine aminotransferase (MtbPSAT) in complex with its cofactor, pyridoxal 5 -phosphate (PLP), is reported. MtbPSAT is an essential enzyme in the biosynthesis of serine and in pathways of one-carbon metabolism. The structure shows that although the Mtb enzyme differs substantially in sequence from other PSAT enzymes, its fold is conserved and its PLP-binding site is virtually identical. Structural comparisons suggest that this site remains unchanged throughout the catalytic cycle. On the other hand, PSAT enzymes are obligate dimers in which the two active sites are located in the dimer interface and distinct differences in the MtbPSAT dimer are noted. These impact on the substrate-binding region and access channel and suggest options for the development of selective inhibitors.
Original languageEnglish
Pages (from-to)553 - 563
Number of pages11
JournalActa Crystallographica Section D: Biological Crystallography
Volume68
Issue number5
DOIs
Publication statusPublished - 2012

Cite this

Coulibaly, Fasseli J ; Lassalle, Edouard ; Baker, Heather M ; Baker, Edward N. / Structure of phosphoserine aminotransferase from Mycobacterium tuberculosis. In: Acta Crystallographica Section D: Biological Crystallography. 2012 ; Vol. 68, No. 5. pp. 553 - 563.
@article{ef1d7f09e6604c5dbce1edfd3516aad2,
title = "Structure of phosphoserine aminotransferase from Mycobacterium tuberculosis",
abstract = "Mycobacterium tuberculosis (Mtb), the causative agent of TB, remains a serious world health problem owing to limitations of the available drugs and the emergence of resistant strains. In this context, key biosynthetic enzymes from Mtb are attractive targets for the development of new therapeutic drugs. Here, the 1.5 A resolution crystal structure of Mtb phosphoserine aminotransferase (MtbPSAT) in complex with its cofactor, pyridoxal 5 -phosphate (PLP), is reported. MtbPSAT is an essential enzyme in the biosynthesis of serine and in pathways of one-carbon metabolism. The structure shows that although the Mtb enzyme differs substantially in sequence from other PSAT enzymes, its fold is conserved and its PLP-binding site is virtually identical. Structural comparisons suggest that this site remains unchanged throughout the catalytic cycle. On the other hand, PSAT enzymes are obligate dimers in which the two active sites are located in the dimer interface and distinct differences in the MtbPSAT dimer are noted. These impact on the substrate-binding region and access channel and suggest options for the development of selective inhibitors.",
author = "Coulibaly, {Fasseli J} and Edouard Lassalle and Baker, {Heather M} and Baker, {Edward N}",
year = "2012",
doi = "10.1107/S0907444912004829",
language = "English",
volume = "68",
pages = "553 -- 563",
journal = "Acta Crystallographica Section D: Structural Biology",
issn = "2059-7983",
publisher = "Wiley-Blackwell",
number = "5",

}

Structure of phosphoserine aminotransferase from Mycobacterium tuberculosis. / Coulibaly, Fasseli J; Lassalle, Edouard; Baker, Heather M; Baker, Edward N.

In: Acta Crystallographica Section D: Biological Crystallography, Vol. 68, No. 5, 2012, p. 553 - 563.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Structure of phosphoserine aminotransferase from Mycobacterium tuberculosis

AU - Coulibaly, Fasseli J

AU - Lassalle, Edouard

AU - Baker, Heather M

AU - Baker, Edward N

PY - 2012

Y1 - 2012

N2 - Mycobacterium tuberculosis (Mtb), the causative agent of TB, remains a serious world health problem owing to limitations of the available drugs and the emergence of resistant strains. In this context, key biosynthetic enzymes from Mtb are attractive targets for the development of new therapeutic drugs. Here, the 1.5 A resolution crystal structure of Mtb phosphoserine aminotransferase (MtbPSAT) in complex with its cofactor, pyridoxal 5 -phosphate (PLP), is reported. MtbPSAT is an essential enzyme in the biosynthesis of serine and in pathways of one-carbon metabolism. The structure shows that although the Mtb enzyme differs substantially in sequence from other PSAT enzymes, its fold is conserved and its PLP-binding site is virtually identical. Structural comparisons suggest that this site remains unchanged throughout the catalytic cycle. On the other hand, PSAT enzymes are obligate dimers in which the two active sites are located in the dimer interface and distinct differences in the MtbPSAT dimer are noted. These impact on the substrate-binding region and access channel and suggest options for the development of selective inhibitors.

AB - Mycobacterium tuberculosis (Mtb), the causative agent of TB, remains a serious world health problem owing to limitations of the available drugs and the emergence of resistant strains. In this context, key biosynthetic enzymes from Mtb are attractive targets for the development of new therapeutic drugs. Here, the 1.5 A resolution crystal structure of Mtb phosphoserine aminotransferase (MtbPSAT) in complex with its cofactor, pyridoxal 5 -phosphate (PLP), is reported. MtbPSAT is an essential enzyme in the biosynthesis of serine and in pathways of one-carbon metabolism. The structure shows that although the Mtb enzyme differs substantially in sequence from other PSAT enzymes, its fold is conserved and its PLP-binding site is virtually identical. Structural comparisons suggest that this site remains unchanged throughout the catalytic cycle. On the other hand, PSAT enzymes are obligate dimers in which the two active sites are located in the dimer interface and distinct differences in the MtbPSAT dimer are noted. These impact on the substrate-binding region and access channel and suggest options for the development of selective inhibitors.

UR - http://www.ncbi.nlm.nih.gov/pubmed/22525753

U2 - 10.1107/S0907444912004829

DO - 10.1107/S0907444912004829

M3 - Article

VL - 68

SP - 553

EP - 563

JO - Acta Crystallographica Section D: Structural Biology

JF - Acta Crystallographica Section D: Structural Biology

SN - 2059-7983

IS - 5

ER -